Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.

Mercer E, Norton T, Woo S, Treister N, Dodson TB, Solomon DH.

Calcif Tissue Int. 2013 Sep;93(3):241-8. doi: 10.1007/s00223-013-9747-1. Epub 2013 Jun 12.

2.

Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.

Di Fede O, Fusco V, Matranga D, Solazzo L, Gabriele M, Gaeta GM, Favia G, Sprini D, Peluso F, Colella G, Vescovi P, Campisi G.

Eur J Intern Med. 2013 Dec;24(8):784-90. doi: 10.1016/j.ejim.2013.05.011. Epub 2013 Jun 12.

PMID:
23768563
3.

Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.

O'Ryan FS, Lo JC.

J Oral Maxillofac Surg. 2012 Aug;70(8):1844-53. doi: 10.1016/j.joms.2011.08.033. Epub 2012 May 16.

PMID:
22595135
4.

Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?

Lescaille G, Coudert AE, Baaroun V, Javelot MJ, Cohen-Solal M, Berdal A, Goudot P, Azérad J, Ruhin B, Descroix V.

J Rheumatol. 2013 Jun;40(6):781-6. doi: 10.3899/jrheum.120810. Epub 2013 Mar 15.

PMID:
23504384
5.

Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw.

Polidoro S, Broccoletti R, Campanella G, Di Gaetano C, Menegatti E, Scoletta M, Lerda E, Matullo G, Vineis P, Berardi D, Scully C, Arduino PG.

Mutat Res. 2013 Oct 9;757(2):104-13. doi: 10.1016/j.mrgentox.2013.07.003. Epub 2013 Jul 24.

6.

Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.

Nomura T, Shibahara T, Uchiyama T, Yamamoto N, Shibui T, Yakushiji T, Watanabe A, Muramatsu K, Ogane S, Murayama M, Sekine R, Nakata E, Fujimoto Y.

Bull Tokyo Dent Coll. 2013;54(2):117-25.

7.

Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?

Ristow O, Gerngroß C, Schwaiger M, Hohlweg-Majert B, Ristow M, Koerdt S, Schuster R, Otto S, Pautke C.

J Cancer Res Clin Oncol. 2014 Mar;140(3):487-93. doi: 10.1007/s00432-014-1588-4. Epub 2014 Jan 28.

PMID:
24469255
8.

Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.

Matsuo A, Hamada H, Kaise H, Chikazu D, Yamada K, Kohno N.

Acta Odontol Scand. 2014 Nov;72(8):656-63. doi: 10.3109/00016357.2014.887772. Epub 2014 Feb 12.

PMID:
24521290
9.

Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.

Pelaz A, Junquera L, Gallego L, García-Consuegra L, García-Martínez L, Cutilli T, Olay S.

Acta Otorrinolaringol Esp. 2015 May-Jun;66(3):139-47. doi: 10.1016/j.otorri.2014.06.003. Epub 2014 Oct 11. English, Spanish.

10.

Extensive Surgical Procedures Result in Better Treatment Outcomes for Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Osteoporosis.

Kim HY, Lee SJ, Kim SM, Myoung H, Hwang SJ, Choi JY, Lee JH, Choung PH, Kim MJ, Seo BM.

J Oral Maxillofac Surg. 2017 Jul;75(7):1404-1413. doi: 10.1016/j.joms.2016.12.014. Epub 2016 Dec 15.

PMID:
28039736
11.

Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.

Khan AA, Rios LP, Sándor GK, Khan N, Peters E, Rahman MO, Clokie CM, Dore E, Dubois S.

J Rheumatol. 2011 Jul;38(7):1396-402. doi: 10.3899/jrheum.100221. Epub 2011 Apr 15.

PMID:
21498483
12.

[The rare case of osteonecrosis of the jaws in a patient treated with bisphosphonates for osteoporosis].

Lewandowski B, Brodowski R, Kość T, Migut M, Wojnar J.

Przegl Lek. 2016;73(1):46-8. Polish.

PMID:
27120948
13.

Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.

Ulmner M, Jarnbring F, Törring O.

J Oral Maxillofac Surg. 2014 Jan;72(1):76-82. doi: 10.1016/j.joms.2013.06.221. Epub 2013 Aug 29.

PMID:
23992777
14.

Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.

Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T.

Int J Oral Maxillofac Surg. 2015 Jul;44(7):840-4. doi: 10.1016/j.ijom.2015.03.013. Epub 2015 Apr 8.

PMID:
25861974
15.

Bisphosphonate-related osteonecrosis of the jaws.

Kushner GM, Alpert B.

Curr Opin Otolaryngol Head Neck Surg. 2011 Aug;19(4):302-6. doi: 10.1097/MOO.0b013e328348b257.

PMID:
21677585
16.

Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC.

J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.

PMID:
19531404
17.

External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.

Thorsteinsson AL, Vestergaard P, Eiken P.

Osteoporos Int. 2014 Jul;25(7):1937-44. doi: 10.1007/s00198-014-2684-7. Epub 2014 Mar 25. Review.

PMID:
24664275
18.

Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.

Assaf AT, Smeets R, Riecke B, Weise E, Gröbe A, Blessmann M, Steiner T, Wikner J, Friedrich RE, Heiland M, Hoelzle F, Gerhards F.

Anticancer Res. 2013 Sep;33(9):3917-24.

PMID:
24023329
19.

Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.

Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mücke T, Mast G, Köhnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Stürzenbaum SR, Schieker M, Pautke C.

J Craniomaxillofac Surg. 2011 Jun;39(4):272-7. doi: 10.1016/j.jcms.2010.05.009. Epub 2010 Jul 2. Review.

PMID:
20580566
20.

The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.

Carlson ER, Basile JD.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.

PMID:
19371819

Supplemental Content

Support Center